Atlas Trials

Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib

Clinical trial NCT07092410 · WITHDRAWN

Trial details

NCT number
NCT07092410
Sponsor
SRH Wald-Klinikum Gera GmbH
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Melanoma BRAF V600E/K Mutated
Start date
2025-08-01
Primary completion
2030-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.